查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1511935

藥品市場規模、佔有率和趨勢分析報告：按產品類型、按地區、細分市場預測，2024-2030 年

Pharmacy Market Size, Share & Trends Analysis Report By Product (Prescription, OTC), By Type (Retail Pharmacy, ePharmacy), By Region (North America, Europe), And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 145 Pages | 商品交期: 2-10個工作天內

價格

醫藥市場的成長與趨勢：

Grand View Research, Inc.最新報告顯示，到2030年，全球藥品市場規模預計將達到2.6兆美元，2024年至2030年複合年成長率為7.28%。

這是由於佔處方藥支出大部分的特殊藥物的使用趨勢，以及慢性病的流行導致對處方藥的需求增加。根據規劃與評估助理部長 2022 年 9 月的統計數據，2021 年特種藥物占美國所有零售藥物支出的 40% 以上，約佔非零售藥物支出的 70%。

近年來，由於技術進步，市場發生了巨大變化。最大的進步之一是電子健康記錄（EHR）的使用。電子病歷允許藥劑師即時存取和更新患者的醫療資訊。這提高了處方箋填寫的效率和準確性，減少了錯誤，並提高了病人的安全。另一項進步是機器人配藥系統，它可以快速且準確地處方箋，從而騰出藥劑師的時間來提供其他患者照護服務。遠距藥事照護是另一項新興技術，它允許藥劑師向服務不足地區的患者遠端提供諮詢和處方箋配藥服務。例如，2020年11月，亞馬遜推出Amazon Pharmacy在美國銷售處方藥。藥房透過使用自動化系統和機器人進行包裝、貼標、填充和配藥，提高了效率並減少了處方箋填充時間。

藥品市場報告亮點

  • 以產品來看，2023年處方箋領域將佔最大佔有率。該領域的成長預計將受到醫療專業人員為治療癌症、糖尿病和心血管疾病等慢性病開出的處方箋數量增加的推動。
  • 按類型分類，零售藥房業務在 2023 年佔據最大收益佔有率。這一成長是由獨立藥局和連鎖店的增加所推動的，這些藥局和連鎖店提供處方箋配藥以外的各種服務，例如免疫服務和健康管理計劃。例如，CVS Health 提供糖尿病護理和慢性腎臟病(CKD) 管理等健康管理計劃，有助於市場擴張。
  • 由於人口老化、處方藥需求增加以及電子藥局服務日益普及等因素，北美在 2023 年佔據市場主導地位。
  • 2023 年 12 月，Rite Aid Corp. 與費城飛人隊合作。此次合作旨在增強費城飛人隊在球迷和球場觀眾中的品牌知名度。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第3章 市場變數、趨勢與範圍

  • 市場體系展望
    • 相關/輔助市場展望
  • 市場趨勢及展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
    • 行業機會
    • 產業挑戰
  • 營商環境分析
    • 產業分析-波特五力分析
    • PESTEL分析
  • COVID-19 影響分析

第4章 產品經營分析

  • 醫藥市場：產品波動分析
  • 產品市場：細分儀表板
  • 2023年及2030年產品趨勢及產品市場佔有率分析
  • 依產品
  • 處方箋
  • OTC

第5章 類型業務分析

  • 藥品市場：類型變異分析
  • 類型市場：細分儀表板
  • 2023 年和 2030 年類型趨勢和市場佔有率分析
  • 按類型
  • 醫院藥房
  • 零售藥房
  • 網路藥局
  • 其他

第6章 區域業務分析

  • 2023 年及 2030 年區域市場佔有率分析
  • 區域市場儀表板
  • 全球區域市場概述
  • 2018-2030年市場規模、預測趨勢分析
  • 北美洲
    • 北美藥局市場，2018-2030
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 歐洲藥局市場，2018-2030
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 瑞典
    • 挪威
    • 丹麥
  • 亞太地區
    • 亞太地區藥品市場，2018-2030
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 泰國
    • 韓國
  • 拉丁美洲
    • 拉丁美洲藥品市場估計與預測，2018-2030
    • 巴西
    • 阿根廷
  • 中東/非洲
    • 2018-2030 年中東和非洲藥品市場估計和預測
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第7章 競爭格局

  • 公司分類
  • 策略規劃
    • 擴張
    • 併購
    • 新服務開始
    • 夥伴關係/協作
    • 其他
  • 公司市場分析
  • 公司簡介/上市公司
    • CVS Health
    • Boots Walgreens
    • Cigna
    • Walmart
    • Kroger
    • Rite Aid Corporation
    • Lloyd Pharmacy
    • Well Pharmacy
    • Humana Pharmacy Solutions
    • Matsumoto Kiyoshi
    • Apollo Pharmacy
    • MedPlusMart.com.
Product Code: GVR-4-68039-701-1

Pharmacy Market Growth & Trends:

The global pharmacy market size is anticipated to reach USD 2.06 trillion by 2030, growing at a CAGR of 7.28% from 2024 to 2030, according to a new report by Grand View Research, Inc. This can be attributed to the growing demand for prescription medications due to a trend towards the use of specialty medications, which account for a significant portion of prescription drug spending, and the increasing prevalence of chronic diseases. According to the Assistant Secretary for Planning and Evaluation statistics of September 2022, in 2021, specialty drugs accounted for more than 40% of overall retail drug spending and around 70% of the no-retail drug spending in the U.S.

Technological advancements have transformed the market in recent years. One of the most significant advancements is using Electronic Health Records (EHRs), which allow pharmacists to access and update patient medical information in real-time. This has improved the efficiency and accuracy of prescription filling, reduced errors, and improved patient safety. Another advancement is robotic dispensing systems, which can fill prescriptions quickly & accurately, freeing up time for pharmacists to provide additional patient care services. Telepharmacy is another emerging technology that allows pharmacists to provide remote consultations and prescription filling services to patients in underserved areas. For instance, in November 2020, Amazon launched Amazon Pharmacy to sell prescription drugs in the U.S. Pharmacies are using automation systems and robots for packaging, labeling, filling, and dispensing to improve efficiency and reduce prescription filling time.

Pharmacy Market Report Highlights:

  • Based on product, prescription segment held the largest share in 2023. The growing number of prescriptions by healthcare professionals for the treatment of chronic conditions such as cancer, diabetes, and cardiovascular diseases is expected to drive the growth of the segment.
  • Based on type, the retail pharmacy segment accounted for the largest revenue share in 2023. This growth is attributed to the increasing number of independent pharmacies and chains offering various services beyond prescription dispensing, such as vaccination services and health management programs. For instance, CVS Health provides health management programs such as diabetes care and chronic kidney disease (CKD) management, contributing to market expansion.
  • North America dominated the market in 2023 due to factors such as the aging population, increasing demand for prescription medications, and the rise in the adoption of e-pharmacy services.
  • In December 2023, Rite Aid Corp partnered with the Philadelphia Flyers. This partnership aimed to help strengthen Philadelphia Flyer's brand awareness among fans and visitors to the arena.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Market Definitions
  • 1.2. Regional Scope
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources & Third-Party Perspectives
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
    • 1.8.2. Volume Price Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Related/Ancillary Market Outlook
  • 3.2. Market Trends and Outlook
  • 3.3. Market Dynamics
    • 3.3.1. Market Driver Analysis
      • 3.3.1.1. Increasing prevalence of chronic diseases
      • 3.3.1.2. Expanding health insurance coverage
      • 3.3.1.3. Technological advancement
      • 3.3.1.4. Increasing demand for specialty drugs
    • 3.3.2. Market Restraint Analysis
      • 3.3.2.1. Product Recalls and Lawsuits
      • 3.3.2.2. Lack of trained staff
    • 3.3.3. Industry Opportunities
    • 3.3.4. Industry Challenges
  • 3.4. Business Environment Analysis
    • 3.4.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
  • 3.5. COVID-19 Impact Analysis

Chapter 4. Product Business Analysis

  • 4.1. Pharmacy Market: Product Movement Analysis
  • 4.2. Pharmacy Product Market: Segment Dashboard
  • 4.3. Product Movement & Market Share Analysis, 2023 & 2030
  • 4.4. Global Pharmacy Market Estimates & Forecast, by Product
  • 4.5. Prescription
    • 4.5.1. Prescription market, 2018 - 2030 (USD Billion)
  • 4.6. OTC
    • 4.6.1. OTC market, 2018 - 2030 (USD Billion)

Chapter 5. Type Business Analysis

  • 5.1. Pharmacy Market: Type Movement Analysis
  • 5.2. Type Market: Segment Dashboard
  • 5.3. Type Movement & Market Share Analysis, 2023 & 2030
  • 5.4. Global Pharmacy Market Estimates & Forecast, by Type
  • 5.5. Hospital Pharmacy
    • 5.5.1. Hospital Pharmacy market, 2018 - 2030 (USD Billion)
  • 5.6. Retail Pharmacy
    • 5.6.1. Retail Pharmacy market, 2018 - 2030 (USD Billion)
    • 5.6.2. Chain
      • 5.6.2.1. Chain Pharmacy market, 2018 - 2030 (USD Billion)
    • 5.6.3. Independent pharmacy
      • 5.6.3.1. Independent pharmacy market, 2018 - 2030 (USD Billion)
    • 5.6.4. Others
      • 5.6.4.1. Others market, 2018 - 2030 (USD Billion)
  • 5.7. ePharmacy
    • 5.7.1. ePharmacy market, 2018 - 2030 (USD Billion)
  • 5.8. Others
    • 5.8.1. Others market, 2018 - 2030 (USD Billion)

Chapter 6. Regional Business Analysis

  • 6.1. Regional Market Share Analysis, 2023 & 2030
  • 6.2. Regional Market Dashboard
  • 6.3. Global Regional Market Snapshot
  • 6.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 6.5. North America
    • 6.5.1. North America Pharmacy Market, 2018 - 2030 (USD Billion)
    • 6.5.2. U.S.
      • 6.5.2.1. Key country dynamics
      • 6.5.2.2. Regulatory framework
      • 6.5.2.3. Competitive scenario
      • 6.5.2.4. U.S. pharmacy market estimates & forecast, 2018 - 2030 (USD Billion)
    • 6.5.3. Canada
      • 6.5.3.1. Key country dynamics
      • 6.5.3.2. Regulatory framework
      • 6.5.3.3. Competitive scenario
      • 6.5.3.4. Canada pharmacy market estimates & forecast, 2018 - 2030 (USD Billion)
    • 6.5.4. Mexico
      • 6.5.4.1. Key country dynamics
      • 6.5.4.2. Regulatory framework
      • 6.5.4.3. Competitive scenario
      • 6.5.4.4. Mexico pharmacy market estimates & forecast,, 2018 - 2030 (USD Billion)
  • 6.6. Europe
    • 6.6.1. Europe Pharmacy Market, 2018 - 2030 (USD Billion)
    • 6.6.2. UK
      • 6.6.2.1. Key country dynamics
      • 6.6.2.2. Regulatory framework
      • 6.6.2.3. Competitive scenario
      • 6.6.2.4. UK pharmacy market estimates & forecast,, 2018 - 2030 (USD Billion)
    • 6.6.3. Germany
      • 6.6.3.1. Key country dynamics
      • 6.6.3.2. Regulatory framework
      • 6.6.3.3. Competitive scenario
      • 6.6.3.4. Germany pharmacy market estimates & forecast, 2018 - 2030 (USD Billion)
    • 6.6.4. France
      • 6.6.4.1. Key country dynamics
      • 6.6.4.2. Regulatory framework
      • 6.6.4.3. Competitive scenario
      • 6.6.4.4. France pharmacy market estimates & forecast, 2018 - 2030 (USD Billion)
    • 6.6.5. Italy
      • 6.6.5.1. Key country dynamics
      • 6.6.5.2. Regulatory framework
      • 6.6.5.3. Competitive scenario
      • 6.6.5.4. Italy pharmacy market estimates & forecast, 2018 - 2030 (USD Billion)
    • 6.6.6. Spain
      • 6.6.6.1. Key country dynamics
      • 6.6.6.2. Regulatory framework
      • 6.6.6.3. Competitive scenario
      • 6.6.6.4. Spain pharmacy market estimates & forecast, 2018 - 2030 (USD Billion)
    • 6.6.7. Sweden
      • 6.6.7.1. Key country dynamics
      • 6.6.7.2. Regulatory framework
      • 6.6.7.3. Competitive scenario
      • 6.6.7.4. Sweden pharmacy market estimates & forecast, 2018 - 2030 (USD Billion)
    • 6.6.8. Norway
      • 6.6.8.1. Key country dynamics
      • 6.6.8.2. Regulatory framework
      • 6.6.8.3. Competitive scenario
      • 6.6.8.4. Norway pharmacy market estimates & forecast, 2018 - 2030 (USD Billion)
    • 6.6.9. Denmark
      • 6.6.9.1. Key country dynamics
      • 6.6.9.2. Regulatory framework
      • 6.6.9.3. Competitive scenario
      • 6.6.9.4. Denmark pharmacy market estimates & forecast, 2018 - 2030 (USD Billion)
  • 6.7. Asia Pacific
    • 6.7.1. Asia Pacific Pharmacy Market, 2018 - 2030 (USD Billion)
    • 6.7.2. Japan
      • 6.7.2.1. Key country dynamics
      • 6.7.2.2. Regulatory framework
      • 6.7.2.3. Competitive scenario
      • 6.7.2.4. Japan pharmacy market estimates & forecast, 2018 - 2030 (USD Billion)
    • 6.7.3. China
      • 6.7.3.1. Key country dynamics
      • 6.7.3.2. Regulatory framework
      • 6.7.3.3. Competitive scenario
      • 6.7.3.4. China pharmacy market estimates & forecast, 2018 - 2030 (USD Billion)
    • 6.7.4. India
      • 6.7.4.1. Key country dynamics
      • 6.7.4.2. Regulatory framework
      • 6.7.4.3. Competitive scenario
      • 6.7.4.4. India pharmacy market estimates & forecast, 2018 - 2030 (USD Billion)
    • 6.7.5. Australia
      • 6.7.5.1. Key country dynamics
      • 6.7.5.2. Regulatory framework
      • 6.7.5.3. Competitive scenario
      • 6.7.5.4. Australia pharmacy market estimates & forecast, 2018 - 2030 (USD Billion)
    • 6.7.6. Thailand
      • 6.7.6.1. Key country dynamics
      • 6.7.6.2. Regulatory framework
      • 6.7.6.3. Competitive scenario
      • 6.7.6.4. Thailand pharmacy market estimates & forecast, 2018 - 2030 (USD Billion)
    • 6.7.7. South Korea
      • 6.7.7.1. Key country dynamics
      • 6.7.7.2. Regulatory framework
      • 6.7.7.3. Competitive scenario
      • 6.7.7.4. South Korea pharmacy market estimates & forecast, 2018 - 2030 (USD Billion)
  • 6.8. Latin America
    • 6.8.1. Latin America Pharmacy Market Estimates & Forecast, 2018 - 2030 (USD Billion)
    • 6.8.2. Brazil
      • 6.8.2.1. Key country dynamics
      • 6.8.2.2. Regulatory framework
      • 6.8.2.3. Competitive scenario
      • 6.8.2.4. Brazil pharmacy market estimates & forecast, 2018 - 2030 (USD Billion)
    • 6.8.3. Argentina
      • 6.8.3.1. Key country dynamics
      • 6.8.3.2. Regulatory framework
      • 6.8.3.3. Competitive scenario
      • 6.8.3.4. Argentina pharmacy market estimates & forecast, 2018 - 2030 (USD Billion)
  • 6.9. MEA
    • 6.9.1. MEA Pharmacy Market Estimates & Forecast, 2018 - 2030 (USD Billion)
    • 6.9.2. South Africa
      • 6.9.2.1. Key country dynamics
      • 6.9.2.2. Regulatory framework
      • 6.9.2.3. Competitive scenario
      • 6.9.2.4. South Africa pharmacy market estimates & forecast, 2018 - 2030 (USD Billion)
    • 6.9.3. Saudi Arabia
      • 6.9.3.1. Key country dynamics
      • 6.9.3.2. Regulatory framework
      • 6.9.3.3. Competitive scenario
      • 6.9.3.4. Saudi Arabia pharmacy market estimates & forecast, 2018 - 2030 (USD Billion)
    • 6.9.4. UAE
      • 6.9.4.1. Key country dynamics
      • 6.9.4.2. Regulatory framework
      • 6.9.4.3. Competitive scenario
      • 6.9.4.4. UAE pharmacy market estimates & forecast, 2018 - 2030 (USD Billion)
    • 6.9.5. Kuwait
      • 6.9.5.1. Key country dynamics
      • 6.9.5.2. Regulatory framework
      • 6.9.5.3. Competitive scenario
      • 6.9.5.4. Kuwait pharmacy market estimates & forecast, 2018 - 2030 (USD Billion)

Chapter 7. Competitive Landscape

  • 7.1. Company Categorization
  • 7.2. Strategy Mapping
    • 7.2.1. Expansion
    • 7.2.2. Merger & Acquisition
    • 7.2.3. New Service Launch
    • 7.2.4. Partnership/Collaborations
    • 7.2.5. Others
  • 7.3. Company market position analysis
  • 7.4. Company Profiles/Listing
    • 7.4.1. CVS Health
      • 7.4.1.1. Overview
      • 7.4.1.2. Financial Performance
      • 7.4.1.3. Service Benchmarking
      • 7.4.1.4. Strategic Initiatives
    • 7.4.2. Boots Walgreens
      • 7.4.2.1. Overview
      • 7.4.2.2. Financial Performance
      • 7.4.2.3. Service Benchmarking
      • 7.4.2.4. Strategic Initiatives
    • 7.4.3. Cigna
      • 7.4.3.1. Overview
      • 7.4.3.2. Financial Performance
      • 7.4.3.3. Service Benchmarking
      • 7.4.3.4. Strategic Initiatives
    • 7.4.4. Walmart
      • 7.4.4.1. Overview
      • 7.4.4.2. Financial Performance
      • 7.4.4.3. Service Benchmarking
      • 7.4.4.4. Strategic Initiatives
    • 7.4.5. Kroger
      • 7.4.5.1. Overview
      • 7.4.5.2. Financial Performance
      • 7.4.5.3. Service Benchmarking
      • 7.4.5.4. Strategic Initiatives
    • 7.4.6. Rite Aid Corporation
      • 7.4.6.1. Overview
      • 7.4.6.2. Financial Performance
      • 7.4.6.3. Service Benchmarking
      • 7.4.6.4. Strategic Initiatives
    • 7.4.7. Lloyd Pharmacy
      • 7.4.7.1. Overview
      • 7.4.7.2. Financial Performance
      • 7.4.7.3. Service Benchmarking
      • 7.4.7.4. Strategic Initiatives
    • 7.4.8. Well Pharmacy
      • 7.4.8.1. Overview
      • 7.4.8.2. Financial Performance
      • 7.4.8.3. Service Benchmarking
      • 7.4.8.4. Strategic Initiatives
      • 7.4.8.5. Strategic Initiatives
    • 7.4.9. Humana Pharmacy Solutions
      • 7.4.9.1. Overview
      • 7.4.9.2. Financial Performance
      • 7.4.9.3. Service Benchmarking
      • 7.4.9.4. Strategic Initiatives
    • 7.4.10. Matsumoto Kiyoshi
      • 7.4.10.1. Overview
      • 7.4.10.2. Financial Performance
      • 7.4.10.3. Service Benchmarking
      • 7.4.10.4. Strategic Initiatives
    • 7.4.11. Apollo Pharmacy
      • 7.4.11.1. Overview
      • 7.4.11.2. Financial Performance
      • 7.4.11.3. Service Benchmarking
      • 7.4.11.4. Strategic Initiatives
    • 7.4.12. MedPlusMart.com.
      • 7.4.12.1. Overview
      • 7.4.12.2. Financial Performance
      • 7.4.12.3. Service Benchmarking
      • 7.4.12.4. Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global pharmacy market, by product, 2018 - 2030 (USD Billion)
  • Table 4 Global pharmacy market, by type, 2018 - 2030 (USD Billion)
  • Table 5 Global pharmacy market, by region, 2018 - 2030 (USD Billion)
  • Table 6 North America pharmacy market, by country, 2018 - 2030 (USD Billion)
  • Table 7 North America pharmacy market, by product, 2018 - 2030 (USD Billion)
  • Table 8 North America pharmacy market, by type, 2018 - 2030 (USD Billion)
  • Table 9 U.S.pharmacy market, by product, 2018 - 2030 (USD Billion)
  • Table 10 U.S pharmacy market, by type, 2018 - 2030 (USD Billion)
  • Table 11 Canada pharmacy market, by product, 2018 - 2030 (USD Billion)
  • Table 12 Canada pharmacy market, by type, 2018 - 2030 (USD Billion)
  • Table 13 Mexico pharmacy market, by product, 2018 - 2030 (USD Billion)
  • Table 14 Mexico pharmacy market, by type, 2018 - 2030 (USD Billion)
  • Table 15 Europe pharmacy market, by country, 2018 - 2030 (USD Billion)
  • Table 16 Europe pharmacy market, by product, 2018 - 2030 (USD Billion)
  • Table 17 Europe pharmacy market, by type, 2018 - 2030 (USD Billion)
  • Table 18 UK pharmacy market, by product, 2018 - 2030 (USD Billion)
  • Table 19 UK pharmacy market, by type, 2018 - 2030 (USD Billion)
  • Table 20 Germany pharmacy market, by product, 2018 - 2030 (USD Billion)
  • Table 21 Germany pharmacy market, by type, 2018 - 2030 (USD Billion)
  • Table 22 France pharmacy market, by product, 2018 - 2030 (USD Billion)
  • Table 23 France pharmacy market, by type, 2018 - 2030 (USD Billion)
  • Table 24 Italy pharmacy market, by product, 2018 - 2030 (USD Billion)
  • Table 25 Italy pharmacy market, by type, 2018 - 2030 (USD Billion)
  • Table 26 Spain pharmacy market, by product, 2018 - 2030 (USD Billion)
  • Table 27 Spain pharmacy market, by type, 2018 - 2030 (USD Billion)
  • Table 28 Sweden pharmacy market, by product, 2018 - 2030 (USD Billion)
  • Table 29 Sweden pharmacy market, by type, 2018 - 2030 (USD Billion)
  • Table 30 Norway pharmacy market, by product, 2018 - 2030 (USD Billion)
  • Table 31 Norway pharmacy market, by type, 2018 - 2030 (USD Billion)
  • Table 32 Denmark pharmacy market, by product, 2018 - 2030 (USD Billion)
  • Table 33 Denmark pharmacy market, by type, 2018 - 2030 (USD Billion)
  • Table 34 Asia Pacific pharmacy market, by country, 2018 - 2030 (USD Billion)
  • Table 35 Asia Pacific pharmacy market, by product, 2018 - 2030 (USD Billion)
  • Table 36 Asia Pacific pharmacy market, by type, 2018 - 2030 (USD Billion)
  • Table 37 Japan pharmacy market, by product, 2018 - 2030 (USD Billion)
  • Table 38 Japan pharmacy market, by type, 2018 - 2030 (USD Billion)
  • Table 39 China pharmacy market, by product, 2018 - 2030 (USD Billion)
  • Table 40 China pharmacy market, by type, 2018 - 2030 (USD Billion)
  • Table 41 India pharmacy market, by product, 2018 - 2030 (USD Billion)
  • Table 42 India pharmacy market, by type, 2018 - 2030 (USD Billion)
  • Table 43 Australia pharmacy market, by product, 2018 - 2030 (USD Billion)
  • Table 44 Australia pharmacy market, by type, 2018 - 2030 (USD Billion)
  • Table 45 Thailand pharmacy market, by product, 2018 - 2030 (USD Billion)
  • Table 46 Thailand pharmacy market, by type, 2018 - 2030 (USD Billion)
  • Table 47 South Korea pharmacy market, by product, 2018 - 2030 (USD Billion)
  • Table 48 South Korea pharmacy market, by type, 2018 - 2030 (USD Billion)
  • Table 49 Latin America pharmacy market, by country, 2018 - 2030 (USD Billion)
  • Table 50 Latin America pharmacy market, by product, 2018 - 2030 (USD Billion)
  • Table 51 Latin America pharmacy market, by type, 2018 - 2030 (USD Billion)
  • Table 52 Brazil pharmacy market, by product, 2018 - 2030 (USD Billion)
  • Table 53 Brazil pharmacy market, by type, 2018 - 2030 (USD Billion)
  • Table 54 Argentina pharmacy market, by product, 2018 - 2030 (USD Billion)
  • Table 55 Argentina pharmacy market, by type, 2018 - 2030 (USD Billion)
  • Table 56 Middle East & Africa pharmacy market, by country, 2018 - 2030 (USD Billion)
  • Table 57 Middle East & Africa pharmacy market, by product, 2018 - 2030 (USD Billion)
  • Table 58 Middle East & Africa pharmacy market, by type, 2018 - 2030 (USD Billion)
  • Table 59 South Africa pharmacy market, by product, 2018 - 2030 (USD Billion)
  • Table 60 South Africa pharmacy market, by type, 2018 - 2030 (USD Billion)
  • Table 61 Saudi Arabia pharmacy market, by product, 2018 - 2030 (USD Billion)
  • Table 62 Saudi Arabia pharmacy market, by type, 2018 - 2030 (USD Billion)
  • Table 63 UAE pharmacy market, by product, 2018 - 2030 (USD Billion)
  • Table 64 UAE pharmacy market, by type, 2018 - 2030 (USD Billion)
  • Table 65 Kuwait pharmacy market, by product, 2018 - 2030 (USD Billion)
  • Table 66 Kuwait pharmacy market, by type, 2018 - 2030 (USD Billion)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Pharmacy market segmentation
  • Fig. 3 Market research process
  • Fig. 4 Data triangulation techniques
  • Fig. 5 Primary research pattern
  • Fig. 6 Market research approaches
  • Fig. 7 Value-chain-based sizing & forecasting
  • Fig. 8 QFD modelling for market share assessment
  • Fig. 9 Market formulation & validation
  • Fig. 10 Market snapshot
  • Fig. 11 Market segmentation
  • Fig. 12 Competitive landscape
  • Fig. 13 Global pharmacy market lineage outlook
  • Fig. 14 Pharmacy market dynamics
  • Fig. 15 Market driver relevance analysis (Current & future impact)
  • Fig. 16 Market restraint relevance analysis (Current & future impact)
  • Fig. 17 Pharmacy market: Porter's five forces analysis
  • Fig. 18 Pharmacy market: PESTLE analysis
  • Fig. 19 Pharmacy market product outlook: Segment dashboard
  • Fig. 20 Pharmacy market: Product movement & market share analysis, 2023 & 2030
  • Fig. 21 Prescription market, 2018 - 2030 (USD Million)
  • Fig. 22 OTC market, 2018 - 2030 (USD Million)
  • Fig. 23 Pharmacy market type outlook: Segment dashboard)
  • Fig. 24 Pharmacy market: type movement & market share analysis, 2023 & 2030
  • Fig. 25 Hospital pharmacy market, 2018 - 2030 (USD Billion)
  • Fig. 26 Retail pharmacy market, 2018 - 2030 (USD Billion)
  • Fig. 27 Chain pharmacy market, 2018 - 2030 (USD Billion)
  • Fig. 28 Independent pharmacy market, 2018 - 2030 (USD Billion)
  • Fig. 29 Other retail pharmacy market, 2018 - 2030 (USD Billion)
  • Fig. 30 ePharmacy market, 2018 - 2030 (USD Billion)
  • Fig. 31 Other pharmacy market, 2018 - 2030 (USD Billion)
  • Fig. 32 Regional marketplace: Key takeaways
  • Fig. 33 North America pharmacy market, 2018 - 2030 (USD Billion)
  • Fig. 34 U.S key country dynamics
  • Fig. 35 U.S pharmacy market, 2018 - 2030 (USD Billion)
  • Fig. 36 Canada key country dynamics
  • Fig. 37 Canada pharmacy market, 2018 - 2030 (USD Billion)
  • Fig. 38 Mexico key country dynamic
  • Fig. 39 Mexico pharmacy market, 2018 - 2030 (USD Billion)
  • Fig. 40 Europe pharmacy market, 2017 - 2030 (USD Billion)
  • Fig. 41 UK key country dynamic
  • Fig. 42 UK pharmacy market, 2018 - 2030 (USD Billion)
  • Fig. 43 Germany key country dynamic
  • Fig. 44 Germany pharmacy market, 2018 - 2030 (USD Billion)
  • Fig. 45 France key country dynamic
  • Fig. 46 France pharmacy market, 2018 - 2030 (USD Billion)
  • Fig. 47 Italy key country dynamic
  • Fig. 48 Italy pharmacy market, 2018 - 2030 (USD Billion)
  • Fig. 49 Spain key country dynamic
  • Fig. 50 Spain pharmacy market, 2018 - 2030 (USD Billion)
  • Fig. 51 Denmark key country dynamic
  • Fig. 52 Denmark pharmacy market, 2018 - 2030 (USD Billion)
  • Fig. 53 Sweden key country dynamic
  • Fig. 54 Sweden pharmacy market, 2018 - 2030 (USD Billion)
  • Fig. 55 Norway key country dynamic
  • Fig. 56 Norway pharmacy market, 2018 - 2030 (USD Billion)
  • Fig. 57 Asia Pacific pharmacy market, 2018 - 2030 (USD Billion)
  • Fig. 58 China key country dynamic
  • Fig. 59 China pharmacy market, 2018 - 2030 (USD Billion)
  • Fig. 60 Japan key country dynamic
  • Fig. 61 Japan pharmacy market, 2018 - 2030 (USD Billion)
  • Fig. 62 India key country dynamic
  • Fig. 63 India pharmacy market, 2018 - 2030 (USD Billion)
  • Fig. 64 South Korea key country dynamic
  • Fig. 65 South Korea pharmacy market, 2018 - 2030 (USD Billion)
  • Fig. 66 Australia key country dynamic
  • Fig. 67 Australia pharmacy market, 2018 - 2030 (USD Billion)
  • Fig. 68 Thailand key country dynamic
  • Fig. 69 Thailand pharmacy market, 2018 - 2030 (USD Billion)
  • Fig. 70 Latin America pharmacy market, 2018 - 2030 (USD Billion)
  • Fig. 71 Brazil key country dynamic
  • Fig. 72 Brazil pharmacy market, 2018 - 2030 (USD Billion)
  • Fig. 73 Argentina key country dynamic
  • Fig. 74 Argentina pharmacy market, 2018 - 2030 (USD Billion)
  • Fig. 75 MEA pharmacy market, 2018 - 2030 (USD Billion)
  • Fig. 76 South Africa key country dynamic
  • Fig. 77 South Africa pharmacy market, 2018 - 2030 (USD Billion)
  • Fig. 78 Saudi Arabia key country dynamic
  • Fig. 79 Saudi Arabia pharmacy market, 2018 - 2030 (USD Billion)
  • Fig. 80 UAE key country dynamic
  • Fig. 81 UAE pharmacy market, 2018 - 2030 (USD Billion)
  • Fig. 82 Kuwait key country dynamic
  • Fig. 83 Kuwait pharmacy market, 2018 - 2030 (USD Billion)
  • Fig. 84 Company categorization
  • Fig. 85 Company market position analysis
  • Fig. 86 Strategic framework